Sep 25, 2025 · Provides updated recommendations for HIV testing by laboratories in the United States and describes approaches for reporting test results to persons ordering HIV tests and to public health …

The following testing recommendations are from current Association of Public Health Laboratories (APHL) and Centers for Disease Control and Prevention (CDC) guidelines.

As of January 1, 2024, the following United States Food and Drug Administration (FDA)-approved tests are available for use in the HIV Diagnostic Testing Algorithm for laboratories.

Nov 8, 2025 · An estimated 15% of patients living with HIV in the U.S. remain unaware of their status. HIV testing should be integrated across all levels of the healthcare system to facilitate early …

Clinicians should offer repeat HIV testing every 3 months, or sooner if acute HIV is suspected, for as long as an individual remains at high risk of HIV exposure.

HIVSS / HIV-1 and HIV-2 Antigen and Antibody Routine Screen, Serum If indicated, all subsequent tests listed are automatically performed and charged separately.

Apr 1, 2025 · In 2014, the CDC and the Association of Public Health Laboratories (APHL) released an HIV diagnostic algorithm to allow for more accurate diagnosis of acute HIV-1, improved ability to …

IV LABORATORY DIAGNOSTIC TESTING ALGORITHM The HIV Laboratory Diagnostic Testing Algorithm1 should be used for testing serum or plasma to diagnose persons with HIV and for the …

25 24 diagnosed HIV to care; diagnose HIV infection earlier; and reduce HIV transmission in the United States. 28 27 These recommendations use standard methods for developing guidelines [8, 9] (Figure …

Laboratories should use this same testing algorithm, beginning with an antigen/antibody immunoassay on all serum or plasma specimens submitted for testing after a preliminary positive result from any …